Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $18,897 - $22,624
-154 Reduced 0.68%
22,385 $3.2 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $127,943 - $170,307
1,253 Added 5.89%
22,539 $2.89 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $59,339 - $71,284
-676 Reduced 3.08%
21,286 $2.2 Million
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $993,883 - $2.18 Million
10,929 Added 99.06%
21,962 $2 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $37,903 - $41,953
243 Added 2.25%
11,033 $1.79 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $700,607 - $842,487
-5,294 Reduced 32.91%
10,790 $1.72 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $9,126 - $12,044
-89 Reduced 0.55%
16,084 $2.18 Million
Q3 2022

Oct 28, 2022

SELL
$95.28 - $116.93 $2,286 - $2,806
-24 Reduced 0.15%
16,173 $1.61 Million
Q2 2022

Jul 29, 2022

BUY
$103.24 - $121.81 $15,382 - $18,149
149 Added 0.93%
16,197 $1.81 Million
Q1 2022

Apr 29, 2022

BUY
$93.1 - $112.54 $71,407 - $86,318
767 Added 5.02%
16,048 $1.78 Million
Q4 2021

Jan 28, 2022

BUY
$95.88 - $117.08 $4,506 - $5,502
47 Added 0.31%
15,281 $1.71 Million
Q3 2021

Nov 02, 2021

BUY
$84.42 - $106.62 $23,975 - $30,280
284 Added 1.9%
15,234 $1.46 Million
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $291,005 - $364,552
4,301 Added 40.39%
14,950 $1.25 Million
Q1 2021

Apr 29, 2021

BUY
$67.06 - $75.82 $153,165 - $173,172
2,284 Added 27.3%
10,649 $718,000
Q4 2020

Feb 08, 2021

BUY
$63.89 - $73.8 $48,300 - $55,792
756 Added 9.94%
8,365 $584,000
Q3 2020

Nov 10, 2020

BUY
$63.69 - $70.22 $19,807 - $21,838
311 Added 4.26%
7,609 $528,000
Q2 2020

Jul 29, 2020

BUY
$58.54 - $67.94 $127,090 - $147,497
2,171 Added 42.34%
7,298 $478,000
Q1 2020

May 06, 2020

BUY
$49.46 - $64.78 $253,581 - $332,127
5,127 New
5,127 $309,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mitchell Capital Management CO Portfolio

Follow Mitchell Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.